surpass 3 tirzepatide Effect of versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase SURPASS-3 Once-weekly tirzepatide versus once-daily insulin

Pivotal trials including SURMOUNT-1, SURMOUNT-2, and SURMOUNT-3 demonstrated that once-weekly tirzepatide injections produced sustained weight loss of 2022% over 68 weeks in people with obesity

Epigallocatechin 3-gallate (EGCG) is a polyphenolic molecule in green tea as a neuroprotective agent

InjectCo begins every program with a detailed online medical evaluation that reviews health history and current concerns

The plan includes a full evaluation with body composition scanning, lab work, coaching, and ongoing follow-ups designed to address nutrition, sleep, stress, and long-term habits so weight stays off rather than returning after a short diet

Cadmium is a heavy and toxic trace metal without an essential role in the human body